Establishment Labs Holdings Inc. (ESTA)
ESTA Stock Price Chart
Explore Establishment Labs Holdings Inc. interactive price chart. Choose custom timeframes to analyze ESTA price movements and trends.
ESTA Company Profile
Discover essential business fundamentals and corporate details for Establishment Labs Holdings Inc. (ESTA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
19 Jul 2018
Employees
1.03k
CEO
Fillipo Peter Caldini
Description
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.
ESTA Financial Timeline
Browse a chronological timeline of Establishment Labs Holdings Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is -$0.34, while revenue estimate is $65.79m.
Earnings released on 6 May 2026
EPS came in at -$0.40 falling short of the estimated -$0.35 by -12.69%, while revenue for the quarter reached $59.88m , beating expectations by +4.32%.
Earnings released on 24 Feb 2026
EPS came in at -$0.09 surpassing the estimated -$0.22 by +58.14%, while revenue for the quarter reached $64.62m , beating expectations by +1.28%.
Earnings released on 5 Nov 2025
EPS came in at -$0.38 surpassing the estimated -$0.54 by +29.63%, while revenue for the quarter reached $53.78m , missing expectations by -15.70%.
Earnings released on 7 Aug 2025
EPS came in at -$0.57 falling short of the estimated -$0.54 by -5.56%, while revenue for the quarter reached $51.30m , missing expectations by -2.25%.
Earnings released on 7 May 2025
EPS came in at -$0.70 surpassing the estimated -$0.83 by +15.66%, while revenue for the quarter reached $41.38m , beating expectations by +0.64%.
Earnings released on 26 Feb 2025
EPS came in at -$0.98 falling short of the estimated -$0.64 by -53.12%, while revenue for the quarter reached $44.51m , beating expectations by +0.15%.
Earnings released on 7 Nov 2024
EPS came in at -$0.59 surpassing the estimated -$0.61 by +3.28%, while revenue for the quarter reached $40.23m , missing expectations by -9.98%.
Earnings released on 6 Aug 2024
EPS came in at -$0.62 falling short of the estimated -$0.51 by -21.57%, while revenue for the quarter reached $44.12m , beating expectations by +2.38%.
Earnings released on 8 May 2024
EPS came in at -$0.58 surpassing the estimated -$0.67 by +13.43%, while revenue for the quarter reached $37.17m , beating expectations by +3.24%.
Earnings released on 28 Feb 2024
EPS came in at -$0.79 surpassing the estimated -$0.91 by +13.19%, while revenue for the quarter reached $31.56m , beating expectations by +0.35%.
Earnings released on 7 Nov 2023
EPS came in at -$1.12 falling short of the estimated -$0.80 by -40.00%, while revenue for the quarter reached $38.51m , beating expectations by +21.39%.
Earnings released on 8 Aug 2023
EPS came in at -$0.65 surpassing the estimated -$0.72 by +9.72%, while revenue for the quarter reached $48.56m , beating expectations by +2.54%.
Earnings released on 8 May 2023
EPS came in at -$0.48 surpassing the estimated -$0.68 by +29.41%, while revenue for the quarter reached $46.52m , beating expectations by +2.36%.
Earnings released on 27 Feb 2023
EPS came in at -$0.55 surpassing the estimated -$0.68 by +19.12%, while revenue for the quarter reached $43.81m , beating expectations by +1.28%.
Earnings released on 7 Nov 2022
EPS came in at -$0.76 falling short of the estimated -$0.54 by -40.74%, while revenue for the quarter reached $38.25m , beating expectations by +2.47%.
Earnings released on 8 Aug 2022
EPS came in at -$0.90 falling short of the estimated -$0.42 by -114.29%, while revenue for the quarter reached $41.19m , beating expectations by +7.28%.
Earnings released on 9 May 2022
EPS came in at -$0.24 surpassing the estimated -$0.38 by +36.84%, while revenue for the quarter reached $38.45m , beating expectations by +9.08%.
Earnings released on 1 Mar 2022
EPS came in at -$0.60 falling short of the estimated -$0.33 by -81.82%, while revenue for the quarter reached $35.31m , beating expectations by +1.32%.
Earnings released on 9 Nov 2021
EPS came in at -$0.61 falling short of the estimated -$0.35 by -74.29%, while revenue for the quarter reached $29.04m , beating expectations by +30.83%.
Earnings released on 29 Jul 2021
EPS came in at -$0.22 surpassing the estimated -$0.28 by +21.43%, while revenue for the quarter reached $31.99m , meeting expectations.
ESTA Stock Performance
Access detailed ESTA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
